Dabur India Limited has presented its Analyst/Institutional Investor Meet presentation for the fiscal year 2027. The presentation covers key strategic initiatives under ‘Vision VII (FY25-28)’, focusing on accelerating profitable growth through core brand acceleration, premiumization, bold bets in health and wellness, portfolio streamlining, GTM 2.0, strategic M&A, and operating efficiencies. It also highlights Q2 FY27 financial performance and business segment contributions.
Dabur India Analyst Meet Presentation for FY27
Dabur India Limited has shared its presentation from the Analyst/Institutional Investor Meet held on November 05, 2026. The comprehensive overview details the company’s strategic vision and performance, aligning with the ‘IGNITE’ theme of ‘Fueling Growth | Winning Together’. The presentation, titled ‘Analyst Meet 2026’, was a conversation with Herjit S. Bhalla.
Vision VII (FY25-28): Strategy for Growth
The company outlined its strategic roadmap for FY25-FY28, titled ‘Vision VII’. Key pillars of this vision include:
- Accelerate Core Brands: Continued investment in core brands and increased spends on digital initiatives.
- Premiumisation & Contemporisation: Serving evolving consumer needs by building a higher-margin portfolio and innovating products, formats, and packaging.
- Bold Bets in Health & Wellness: Focusing on everyday solutions for lifestyle needs in areas like Gut Health, Functional Beverages, and Strength & Vitality.
- Streamline Portfolio: Disciplined approach to discontinue non-performing brands and SKUs to release capital for focused bets.
- GTM 2.0: Project Saksham: Realigning Go-to-Market strategies with distributor consolidation, increased throughput, and lower stockist attrition.
- Strategic M&A: Evaluating inorganic growth through minority stakes in D2C companies and strategic acquisitions.
- Operating Efficiencies: Driving greater efficiency, agility, and digital integration across the value chain, targeting significant savings and reinvestment in brand building.
Key Highlights and Financial Performance (Q2 FY27)
The presentation also provided an update on the company’s financial performance for Q2 FY27, showcasing strong topline delivery:
- Consolidated Performance: Revenue grew by 11.6% to INR 3,563 Cr, with PAT growing 11.7% to INR 505 Cr.
- India Standalone: Revenue increased by 8.9% to INR 2,433 Cr, and PAT grew 11.2%.
- India FMCG: Recorded revenue growth of 10.7%, with volume growth at 5.5%.
- International Business: Reported revenue growth of 20.0%.
Additionally, the company highlighted key quarter achievements including 10.7% growth in India FMCG, sequential recovery in the beverage category, mid to high single-digit growth in General Trade, and strong double-digit growth in alternate channels. Dabur’s ESG rating was also updated to 86 by DJSI.
Dabur’s Right to Win
The presentation emphasized Dabur’s strong foundation for future growth, driven by favourable demographics, rising per capita spends, a fast-growing economy, under-penetration in the US market, a digital-first Bharat, quick commerce surge, and growing demand for health and wellness products. The company highlighted its own strengths including headroom for growth, natural and Ayurvedic equity backed by science, rural reach, and demonstrated capability in alternate channels.
Source: BSE
